Latest Stem cell treatments Stories
Transplantation of human stem cells in an experiment conducted at the University of Wisconsin-Madison improved survival and muscle function in rats used to model ALS, a nerve disease that destroys nerve control of muscles, causing death by respiratory failure. ALS (amyotrophic lateral sclerosis) is sometimes called "Lou Gehrig's disease." According to the ALS Association, the condition strikes about 5,600 Americans each year. Only about half of patients are alive three years after...
Brett Smith for redOrbit.com - Your Universe Online For years, stem-cell based therapies have been described as a potential way to treat spinal cord injuries in humans, and a new study published in the journal Stem Cell Research and Therapy describes an exciting step forward in that pursuit. According to the report, a single injection of human stem cells was able to induce neuronal regeneration and improved mobility in rats that were afflicted with a severe spinal cord injury. "This...
redOrbit Staff & Wire Reports - Your Universe Online More than half of the seriously disabled stroke victims participating in preliminary clinical trials of a new stem cell procedure have shown modest signs of recovery, the scientists carrying out the research reported Monday. According to Sam Marsden of The Telegraph, five out of the nine ischemic stroke patients taking part in the PISCES trial were able to regain some movement in their hands and legs after undergoing the...
Study into effect of adult stem cells on disease continues. Tijuana, Mexico (PRWEB) May 27, 2013 Regenerative Medicine Institute, Mexico (RMI) recently hit the three year milestone in its clinical research trial of adult stem cells. The trial seeks to discover the impact of stem cells on degenerative conditions such as heart disease, COPD, vascular issues, orthopedic conditions, and other chronic health problems. Regenerative Medicine is an institute of board certified, multi-specialty...
The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million (Over $3 Million USD) with non equity based funding of close to 50% JERUSALEM, May 23, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that its portfolio company,...
A new study appearing in the current issue of STEM CELLS Translational Medicine indicates that stem cells harvested from fat (adipose) are more potent than those collected from bone marrow in helping to modulate the body’s immune system. Durham, NC (PRWEB) May 21, 2013 A new study appearing in the current issue of STEM CELLS Translational Medicine indicates that stem cells harvested from fat (adipose) are more potent than those collected from bone marrow in helping to modulate the...
Awards address many debilitating diseases; include pre-clinical research and a clinical trial COLUMBIA, Md., May 21, 2013 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) has completed its review of the 171 applications received in response to its FY 2013 Requests for Applications (RFAs). The board of directors of the Maryland Technology Development Corporation (TEDCO) approved the Commission's recommendation to fund 31 new proposals with the Maryland Stem Cell...
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert L. Wilensky, MD, Professor of Medicine and Director of Interventional Cardiology Research at the University of Pennsylvania has agreed to join the Scientific and Medical Advisory Board for Stemedica’s Cardiology Division. San Diego, CA (PRWEB) May 20, 2013 Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing,...
Data Shows, Early Stem Cell Transplantation Could Slow Progression Or Even Improve Patient's Condition in Some Forms of ALS ROCKVILLE, Md., May 20, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that Eva Feldman, MD, PhD, principal investigator, presented updated Phase I data from its spinal cord-derived human neural stem cell (NSI-566) trial in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the neuro diabetes special...
SALT LAKE CITY, May 20, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced the launch of a new service offering for the storage of mesenchymal cells through its wholly owned subsidiary CorCell Companies, Inc. (CorCell). For additional information on the new service offering please visit our cord tissue web page. "As we continue to evaluate the advancing science of stem cells, it is clear to...
